Veryan in the media
MIMICS-2 at 1 year: 3-D stent meets safety & effectiveness goals
Article on Dr T. M. Sullivan’s ISET presentation
Professor Thomas Zeller, MD – Director of Department of Angiology at Universitats Herzzentrum Freiburg-Bad Krozingen, Germany
Dr Michael Lichtenberg, MD – Director of Angiology Department at the Vascular Centre Clinic Arnsberg, Germany
Professor Gunnar Tepe, MD – Head of Diagnostic & Interventional Radiology at Academic Hospital RoMed Clinic of Rosenheim, Germany
Professor Timothy Sullivan, MD – Chairman of Department of Vascular & Endovascular Surgery & Medical Director of Abbot Northwestern Vascular Center, Minneapolis, Minnesota, USA
NUI Galway will confer six outstanding leaders of the Irish medical technology (medtech) sector with honorary degrees on Monday 26 September.
Those to be conferred are:
- John Power, Founder and CEO of Aerogen;
- Helen Ryan, Former CEO of Creganna;
- Ian Quinn, Founder and Former CEO, Creganna;
- John O’Dea, Founder and CEO of Crospon;
- Paul Gilson, Co-Founder of MedNova and Veryan;
- John O’Shaughnessy, Founder of MedNova and Neuravi.
For full story please click link http://bit.ly/2dbl5Dt
CX 2016 – Good day for drug-coated balloons, swirling flow stents and drug-eluting stents
Professor Peter Gaines, Sheffield,UK, made the case for why inducing swirling flow improves the outcome from endovascular procedures…
The technology transfer, incubation and venture investment company Imperial Innovations, Veryan’s largest investor with a 44.3% shareholding, is proposing to increase its investment in the company, in order to help fund future growth…
One of the most interesting emerging competitors in the peripheral vascular stenting space is UK-based Veryan Medical Ltd. The privately held, venture funded company has developed a unique yet straightforward method of producing…
On May 21, Veryan Medical Ltd. presented data during the Trials and Innovations for Peripheral Interventions Session at EuroPCR 2013 in Paris, France, on its Biomimics 3D stent. A recent trial has demonstrated safety and promising…
Novel ‘3D’ Stent Improves Clinical Status in Femoropopliteal Disease Patients
PARIS, France—A “3D” helical stent that mimics the natural vascular curvature helps improve clinical symptoms and walking distance at 12 months in patients with femoropopliteal disease, according to results…
Data presented here today during the Trials and Innovations for Peripheral Interventions Session at EuroPCR 2013 show that a stent with unique three-dimensional helical geometry, BioMimics 3D™, developed by Veryan Medical Ltd…
The Director of the Department of Angiology at Universitaets-Herzzentrum talks data on renal denervation, drug-eluting balloons, and other recent trials.
Imperial Innovations has made significant progress in continuing not only to create new, exciting and innovative companies, but in nurturing existing companies towards important inflection points.
The city’s med tech cluster has been the springboard for a start-up which, armed with almost €30m in funding, is on the cusp of a global breakthrough.
The Wonderful World of Blood with Michael Mosley – BBC4
Click Here to watch the video.